Emerging Therapies For Newly Diagnosed Or Relapsed AML Patients

Editor

6 years ago

Keith Pratz, MD Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, discusses Emerging Therapies For Newly Diagnosed Or Relapsed AML Patients. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com